FHIR © HL7.org | Server Home | FHIR Server FHIR Server 3.7.13 | FHIR Version n/a User: [n/a]

698091001: Canakinumab (substance)

Status: current, Primitive. Date: 31-Jan 2014. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2971724019 Canakinumab (substance) en Fully specified name Active Case insensitive SNOMED CT core

2971764015 Canakinumab en Synonym Active Case insensitive SNOMED CT core

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Canakinumab	Is a	Monoclonal antibody agent	false	Inferred relationship	Some
Canakinumab	Is a	Interleukin 1 receptor antagonist	true	Inferred relationship	Some
Canakinumab	Is a	Monoclonal antibody	true	Inferred relationship	Some
Canakinumab	Has disposition	Interleukin 1 receptor antagonist	true	Inferred relationship	Some
Canakinumab	Is a	Immunologic agent	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Canakinumab only product	Has active ingredient	True	Canakinumab	Inferred relationship	Some	1
Canakinumab-containing product in parenteral dose form	Has active ingredient	True	Canakinumab	Inferred relationship	Some	1
Canakinumab 150 mg/mL solution for injection	Has BoSS	True	Canakinumab	Inferred relationship	Some	1
Canakinumab 150 mg/mL solution for injection	Has precise active ingredient	True	Canakinumab	Inferred relationship	Some	1
Canakinumab 150 mg lyophilised powder for solution for injection vial	Has BoSS	False	Canakinumab	Inferred relationship	Some	1
Canakinumab 150 mg lyophilised powder for solution for injection vial	Has precise active ingredient	False	Canakinumab	Inferred relationship	Some	1
Canakinumab only product in parenteral dose form	Has active ingredient	True	Canakinumab	Inferred relationship	Some	1
Canakinumab 150 mg powder for solution for injection vial	Has precise active ingredient	True	Canakinumab	Inferred relationship	Some	1
Canakinumab 150 mg powder for solution for injection vial	Has BoSS	True	Canakinumab	Inferred relationship	Some	1
Canakinumab-containing product	Has active ingredient	True	Canakinumab	Inferred relationship	Some	1
Canakinumab 150mg powder for injection solution	Has active ingredient	False	Canakinumab	Inferred relationship	Some

Reference Sets

Substance foundation reference set